VERA — Vera Therapeutics, Inc.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1831828 ·
Last close
$26.20
Market Cap
$1.89B
52W High
$56.05
52W Low
$25.82
ADV30
1,594,066
Next earnings
2026-11-05

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 10,277,000 6,981,000 -95,702,000 -93,711,000 465,752,000 55,322,000 132,566,000
Jun 2026 0 — -112,490,000 -109,473,000 532,984,000 48,876,000 125,226,000
Mar 2026 0 — -125,132,000 -121,032,000 621,739,000 114,351,000 122,042,000
Dec 2025 0 — -94,206,000 -91,097,000 734,733,000 354,725,000 130,212,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-338,653,000
Investing CF
$45,469,000
Financing CF
$292,939,000
CapEx
$-522,000
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-5.67
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-991,370,000
Inventory
—
Receivables
$3,928,000
ST Investments
$450,285,000
EBIT TTM
$-394,359,000
Pretax Income TTM
$-401,894,000
Interest Exp TTM
$7,535,000
Analysts
14

Yahoo Snapshot (yfinance, live)

Total Revenue
$10,277,000
EBITDA
$-426,300,000
Free Cash Flow
$-244,618,256
Enterprise Value
$1,846,167,808
Total Cash
$384,041,984
Total Debt
$76,791,000
Shares Out
72,298,770
Trailing EPS
$-5.90
Book Value
$4.61
ROE
-113.5%
ROA
-54.4%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 0 -315,473,000 -299,615,000 734,733,000 130,212,000 604,521,000 -241,104,000
Dec 2024 0 -167,170,000 -152,148,000 655,681,000 78,526,000 577,155,000 -134,679,000
Dec 2023 0 -102,012,000 -95,990,000 175,546,000 73,861,000 101,685,000 -92,181,000
Dec 2022 0 -90,903,000 -89,056,000 131,435,000 54,527,000 76,908,000 -67,596,000

TTM Snapshot

Revenues TTM
$22,956,000
NetIncome TTM
$-401,895,000
OpCashFlow TTM
—
Assets (Latest)
$532,984,000
Forward EPS
$-4.12

Max Pain — expiry 2027-01-15

max pain strike: $35.00 · spot: $25.58 · call oi: 3,496 · put oi: 15,924
Expected Move to 2027-01-15: ±$4.60 (17.98%) — implied range $20.98 – $30.18 · ATM straddle on $25.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
SEPN Septerna, Inc. $1.90B $40.02 —
ZBIO Zenas BioPharma, Inc. $1.88B $27.75 —
HMDCF HUTCHMED (China) Ltd $1.88B $2.16 —
TRVI Trevi Therapeutics, Inc. $1.93B $13.51 —
HRMY Harmony Biosciences Holdings, Inc. $1.94B $33.01 —

News headlines (Yahoo Finance, 1h cache)

Vera Therapeutics Inc (VERA) (Q3 2026) Earnings Call Highlights: TRUTAKNA Launch Off to a ...
2026-11-07 08:09 · Yahoo
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-11-06 21:05 · Yahoo
Vera Therapeutics Q3 Earnings Call Highlights
2026-11-06 20:14 · Yahoo
Vera Therapeutics (VERA) Stock Looks Above Fair Value After A 148% Run
2026-11-06 14:12 · Yahoo
Vera Therapeutics, Inc. Q3 2026 Earnings Call Summary
2026-11-06 13:30 · Yahoo
Vera Therapeutics (VERA) Q3 2026 Earnings Call Transcript
2026-11-06 07:01 · Yahoo
Vera Therapeutics, Inc. (VERA) Reports Q3 Loss, Tops Revenue Estimates
2026-11-05 21:45 · Yahoo
Vera Therapeutics Provides Business Update and Reports Third Quarter 2026 Financial Results
2026-11-05 21:01 · Yahoo
Vera Therapeutics to Participate in the Guggenheim 3rd Annual Healthcare Innovation Conference
2026-11-02 13:00 · Yahoo
Vera Therapeutics' TRUTAKNA Delivers Strong Phase III IgA Nephropathy Results
2026-10-23 01:04 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.